 Peptide Fragments
"Peptide Fragments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
| Descriptor ID |
D010446
|
| MeSH Number(s) |
D12.644.541
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptide Fragments".
Below are MeSH descriptors whose meaning is more specific than "Peptide Fragments".
This graph shows the total number of publications written about "Peptide Fragments" by people in this website by year, and whether "Peptide Fragments" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 4 | 2 | 6 | | 1992 | 5 | 3 | 8 | | 1993 | 3 | 4 | 7 | | 1994 | 8 | 8 | 16 | | 1995 | 6 | 7 | 13 | | 1996 | 6 | 10 | 16 | | 1997 | 5 | 13 | 18 | | 1998 | 8 | 14 | 22 | | 1999 | 8 | 5 | 13 | | 2000 | 7 | 17 | 24 | | 2001 | 8 | 16 | 24 | | 2002 | 11 | 15 | 26 | | 2003 | 17 | 14 | 31 | | 2004 | 10 | 18 | 28 | | 2005 | 13 | 4 | 17 | | 2006 | 11 | 7 | 18 | | 2007 | 10 | 9 | 19 | | 2008 | 8 | 7 | 15 | | 2009 | 8 | 8 | 16 | | 2010 | 13 | 10 | 23 | | 2011 | 15 | 12 | 27 | | 2012 | 7 | 8 | 15 | | 2013 | 9 | 6 | 15 | | 2014 | 8 | 6 | 14 | | 2015 | 4 | 8 | 12 | | 2016 | 5 | 11 | 16 | | 2017 | 4 | 7 | 11 | | 2018 | 3 | 7 | 10 | | 2019 | 10 | 2 | 12 | | 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Peptide Fragments" by people in Profiles.
-
Gluckman TJ, Wang L, Spinelli KJ, Petersen JL, Huang P, Amin A, Messenger JC, Rao SV. Differential Use and Impact of Bleeding Avoidance Strategies on Percutaneous Coronary Intervention-Related Bleeding Stratified by Predicted Risk. Circ Cardiovasc Interv. 2020 06; 13(6):e008702.
-
Beyer JT, Lind SE, Fisher S, Trujillo TC, Wempe MF, Kiser TH. Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients. J Thromb Thrombolysis. 2020 Feb; 49(2):259-267.
-
Vugmeyster L, Ostrovsky D, Fu R. Deuteron Quadrupolar Chemical Exchange Saturation Transfer (Q-CEST) Solid-State NMR for Static Powder Samples: Approach and Applications to Amyloid-ß Fibrils. Chemphyschem. 2020 02 04; 21(3):220-231.
-
Cruz-Torres I, Backos DS, Herson PS. Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX. Mol Pharmacol. 2020 02; 97(2):102-111.
-
Swanson CM, Kohrt WM, Wolfe P, Wright KP, Shea SA, Cain SW, Munch M, Vujovic N, Czeisler CA, Orwoll ES, Buxton OM. Rapid suppression of bone formation marker in response to sleep restriction and circadian disruption in men. Osteoporos Int. 2019 Dec; 30(12):2485-2493.
-
Laskowski J, Philbrook HT, Parikh CR, Thurman JM. Urine complement activation fragments are increased in patients with kidney injury after cardiac surgery. Am J Physiol Renal Physiol. 2019 09 01; 317(3):F650-F657.
-
Vugmeyster L, Au DF, Ostrovsky D, Fu R. Deuteron Solid-State NMR Relaxation Measurements Reveal Two Distinct Conformational Exchange Processes in the Disordered N-Terminal Domain of Amyloid-ß Fibrils. Chemphyschem. 2019 07 02; 20(13):1680-1689.
-
Hu ZW, Vugmeyster L, Au DF, Ostrovsky D, Sun Y, Qiang W. Molecular structure of an N-terminal phosphorylated ß-amyloid fibril. Proc Natl Acad Sci U S A. 2019 06 04; 116(23):11253-11258.
-
Katsuda M, Miyazawa M, Ojima T, Katanuma A, Hakamada K, Sudo K, Asahara S, Endo I, Ueno M, Hara K, Yamada S, Fujii T, Satoi S, Ioka T, Ohira M, Akahori T, Kitano M, Nagano H, Furukawa M, Adachi T, Yamaue H. A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy. Trials. 2019 Apr 27; 20(1):242.
-
Wang Y, Sosinowski T, Novikov A, Crawford F, White J, Jin N, Liu Z, Zou J, Neau D, Davidson HW, Nakayama M, Kwok WW, Gapin L, Marrack P, Kappler JW, Dai S. How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes. Sci Immunol. 2019 04 05; 4(34).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|